Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impaired renal function in progressive multiple sclerosis.

P A Calabresi1, H Austin, M K Racke

  • 1Department of Neurology, University of Maryland School of Medicine, Baltimore 21201, USA. pcala001@Umaryland.edu

Neurology
|December 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "A five-year multicentre evaluation of candidaemia in UK adults: Epidemiology, risk factors and outcomes" [J Infect 92 (2026) 106692].

The Journal of infection·2026
Same author

A five-year multicentre evaluation of candidaemia in UK adults: Epidemiology, risk factors and outcomes.

The Journal of infection·2026
Same author

Exploring environmental nanobiogeochemistry using field-flow fractionation and ICP-MS-based tools: background and fundamentals.

Environmental science. Nano·2025
Same author

Exploring environmental nanobiogeochemistry using field-flow fractionation and ICP-MS-based tools: progress and frontiers.

Environmental science. Nano·2025
Same author

Bluetongue disease in sheep in New South Wales - April 2023.

Australian veterinary journal·2023
Same author

Co-design of interventions to improve acute care in hospital: A rapid review of the literature and application of the BASE methodology, a novel system for the design of patient centered service prototypes.

Acute medicine·2023
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Patients with progressive Multiple Sclerosis (MS) show impaired kidney function, with significantly lower glomerular filtration rates (GFR) than predicted. This finding is crucial for managing MS treatment safely.

Area of Science:

  • Nephrology
  • Neurology
  • Immunology

Background:

  • Multiple Sclerosis (MS) is a progressive neurological disease.
  • Potential impact of MS on renal function is not well-established.
  • Nephrotoxic drug considerations in MS management require understanding of kidney health.

Purpose of the Study:

  • To assess renal function in patients with progressive Multiple Sclerosis (MS).
  • To determine the prevalence of impaired kidney function in this cohort.
  • To evaluate the implications for therapeutic strategies involving potentially nephrotoxic agents.

Main Methods:

  • Analysis of renal function parameters in 25 patients diagnosed with progressive MS.
  • Measurement of glomerular filtration rate (GFR) and serum creatinine levels.

Related Experiment Videos

  • Comparison of observed values against predicted normal values and standard estimations.

    • Main Results:

    • Mean GFR was significantly lower (92 mL/min/1.73 m(2)) than predicted (110 mL/min/1.73 m(2)), p < 0.001.
    • 36% of patients (9 out of 25) exhibited abnormally low GFR (<90 mL/min/1.73 m(2)).
    • Serum creatinine levels were lower than predicted, leading to poor GFR estimation by standard equations.

    Conclusions:

    • Progressive MS is associated with impaired renal function.
    • Standard equations may inaccurately estimate GFR in MS patients.
    • Findings necessitate careful consideration of nephrotoxic drug use in progressive MS management.